Table 2A.
Factors | Dormancy duration (days) | Sprout length (mm) | |
---|---|---|---|
Treatment (T) | Control | 55.2a | 2.81c |
60 mgL−1 BAP | 36.6c | 3.43b | |
20 mgL−1 GA3 | 46.2b | 4.01a | |
60 mgL−1 BAP + 20 mgL−1 GA3 | 37.5c | 4.12a | |
LSD T (P ≤ 0.05) | 1.18 | 0.142 | |
Genotype (G) | FD51-5 | 30.6d | 3.35b |
PRI Red | 27.5e | 7.09a | |
Sante | 43.1c | 3.41b | |
FD73-49 | 43.1c | 3.51b | |
FD69-1 | 57.7b | 2.33c | |
FD8-1 | 61.2a | 1.87d | |
LSD G (P ≤ 0.05) | 1.45 | 0.174 | |
LSD T × G (P ≤ 0.05) | 2.901 | 0.348 |
BAP, benzylaminopurine; GA3, gibberellic acid.
Treatment means followed by the same letter are not significantly different.
BAP, benzylaminopurine; GA3, gibberellic acid; LSD, least significant difference.